Natural Products as Sources of New Drugs from 1981 to 2014.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Natural Products

• Publication date

  2016-02-07

• Fields of study

  Medicine, Business, Chemistry

• Identifiers
  DOI 10.1021/acs.jnatprod.5b01055PMID 26852623
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Developing natural product drugs: Supply problems and how they have been overcome.

  2016cited by this paper
• Prospecting for new bacterial metabolites: a glossary of approaches for inducing, activating and upregulating the biosynthesis of bacterial cryptic or silent natural products.

  2016cited by this paper
• Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study.

  2016cited by this paper
• Recent advances in engineering nonribosomal peptide assembly lines.

  2016cited by this paper
• Dereplication, sequencing and identification of peptidic natural products: from genome mining to peptidogenomics to spectral networks.

  2016cited by this paper
• New tools for reconstruction and heterologous expression of natural product biosynthetic gene clusters.

  2016cited by this paper
• Pharmaceuticals that contain polycyclic hydrocarbon scaffolds.

  2015cited by this paper
• "Pruning of biomolecules and natural products (PBNP)": an innovative paradigm in drug discovery.

  2015cited by this paper
• The year's new drugs & biologics, 2014: Part I.

  2015cited by this paper
• Spongosine production by a Vibrio harveyi strain associated with the sponge Tectitethya crypta.

  2015cited by this paper
• Academia–Industry Symbiosis in Organic Chemistry

  2015cited by this paper
• Recognition of the role of Natural Products as drugs to treat neglected tropical diseases by the 2015 Nobel prize in physiology or medicine.

  2015cited by this paper
• Learning from PAINful lessons.

  2015cited by this paper
• Can Invalid Bioactives Undermine Natural Product-Based Drug Discovery?

  2015cited by this paper
• Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum

  2015cited by this paper
• Chemical libraries: How dark is HTS dark matter?

  2015cited by this paper
• Design and synthesis of analogues of natural products.

  2015cited by this paper
• FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma

  2015cited by this paper
• The re-emergence of natural products for drug discovery in the genomics era

  2015cited by this paper
• Proteasome inhibitors.

  2015cited by this paper
• (−)‐Tarchonanthuslactone: Design of New Analogues, Evaluation of their Antiproliferative Activity on Cancer Cell Lines, and Preliminary Mechanistic Studies

  2015cited by this paper
• Hexacyclopeptides secreted by an endophytic fungus Fusarium solani N06 act as crosstalk molecules in Narcissus tazetta

  2015cited by this paper
• Implications of endophyte-plant crosstalk in light of quorum responses for plant biotechnology

  2015cited by this paper
• Synthetic approaches to the 2013 new drugs.

  2015cited by this paper
• Bioactive Compounds from Marine Extremophiles

  2015cited by this paper
• Identification and analysis of the bacterial endosymbiont specialized for production of the chemotherapeutic natural product ET-743.

  2015cited by this paper
• Dark chemical matter as a promising starting point for drug lead discovery.

  2015cited by this paper
• Analysis of Physicochemical Properties for Drugs of Natural Origin.

  2015cited by this paper
• The expanding role of immunopharmacology: IUPHAR Review 16

  2015cited by this paper
• Empagliflozin, an SGLT2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

  2015cited by this paper
• Ten things you should know about protein kinases: IUPHAR Review 14

  2015cited by this paper
• Antiviral drug discovery: broad-spectrum drugs from nature.

  2015cited by this paper
• Structure diversification of vancomycin through peptide-catalyzed, site-selective lipidation: a catalysis-based approach to combat glycopeptide-resistant pathogens.

  2015cited by this paper
• Flavonolignans from Aspergillus iizukae, a fungal endophyte of milk thistle (Silybum marianum).

  2014cited by this paper
• Academic-industrial partnerships in drug discovery and development.

  2014cited by this paper
• Tofogliflozin: First Global Approval

  2014cited by this paper
• Modulators of protein-protein interactions.

  2014cited by this paper
• Natural products as leads to antitumor drugs

  2014cited by this paper
• Natural products in medicine: transformational outcome of synthetic chemistry.

  2014cited by this paper
• The year's new drugs & biologics, 2013: Part II.

  2014cited by this paper
• Endophytes are hidden producers of maytansine in Putterlickia roots.

  2014cited by this paper
• Small molecule modulators of protein-protein interactions: selected case studies.

  2014cited by this paper
• Industrial natural product chemistry for drug discovery and development.

  2014cited by this paper
• Ataluren: First Global Approval

  2014cited by this paper
• Phenotypic screening in cancer drug discovery — past, present and future

  2014cited by this paper
• Conformational Analysis of the DFG-Out Kinase Motif and Biochemical Profiling of Structurally Validated Type II Inhibitors

  2014cited by this paper
• The European Medicines Agency approval of 5-aminolaevulinic acid (Ameluz) for the treatment of actinic keratosis of mild to moderate intensity on the face and scalp: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use

  2014cited by this paper
• The chemistry-biology-medicine continuum and the drug discovery and development process in academia.

  2014cited by this paper
• An environmental bacterial taxon with a large and distinct metabolic repertoire

  2014cited by this paper
• Development of a concise synthesis of (+)-ingenol.

  2014cited by this paper
• Macrocycles in Drug Discovery

  2014cited by this paper
• The development of immunoconjugates for targeted cancer therapy

  2014cited by this paper
• Solid-phase peptide synthesis: an overview focused on the preparation of biologically relevant peptides

  2014cited by this paper
• Natural product and natural product derived drugs in clinical trials.

  2014cited by this paper
• Chemistry: Chemical con artists foil drug discovery

  2014cited by this paper
• Bioactive Compounds from Terrestrial Extremophiles

  2014cited by this paper
• Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates.

  2014cited by this paper
• Clinical development success rates for investigational drugs

  2014cited by this paper
• The year's new drugs & biologics, 2013: Part I.

  2014cited by this paper
• Natural product synthesis in the age of scalability.

  2014cited by this paper
• Synthetic approaches to the 2012 new drugs.

  2014cited by this paper
• The European Medicines Agency review of pixantrone for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin's B-cell lymphomas: summary of the scientific assessment of the committee for medicinal products for human use.

  2013cited by this paper
• Homoharringtonine/omacetaxine mepesuccinate: the long and winding road to food and drug administration approval.

  2013cited by this paper
• Natural products: a continuing source of novel drug leads.

  2013cited by this paper
• From epoxomicin to carfilzomib: chemistry, biology, and medical outcomes.

  2013cited by this paper
• 2012 in review - part I: the year's new drugs & biologics.

  2013cited by this paper
• Discovery and development of natural compounds into medicinal products

  2013cited by this paper
• Synthetic approaches to the 2011 new drugs.

  2013cited by this paper
• Natural-product-derived fragments for fragment-based ligand discovery

  2012cited by this paper
• Natural products as sources of new drugs over the 30 years from 1981 to 2010.

  2012cited by this paper
• Discovery of small molecule cancer drugs: Successes, challenges and opportunities

  2012cited by this paper
• Biosynthetic medicinal chemistry of natural product drugs

  2012cited by this paper
• Synthetic approaches to the 2010 new drugs.

  2012cited by this paper
• Discovery of Ipragliflozin (ASP1941): a novel C-glucoside with benzothiophene structure as a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitus.

  2012cited by this paper
• Opportunities for Synthetic Biology in Antibiotics: Expanding Glycopeptide Chemical Diversity

  2012cited by this paper
• The year's new drugs & biologics, 2011.

  2012cited by this paper
• Dual inhibitors for aspartic proteases HIV-1 PR and renin: advancements in AIDS-hypertension-diabetes linkage via molecular dynamics, inhibition assays, and binding free energy calculations.

  2012cited by this paper
• Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): a highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

  2012cited by this paper
• The year's new drugs & biologics, 2010.

  2011cited by this paper
• Conformational Properties and Energetic Analysis of Aliskiren in Solution and Receptor Site

  2011cited by this paper
• Brentuximab vedotin: delivering an antimitotic drug to activated lymphoma cells

  2011cited by this paper
• Trastuzumab emtansine, tumor-activated prodrug (TAP) immunoconjungate, oncolytic

  2011cited by this paper
• Synthetic approaches to the 2009 new drugs.

  2011cited by this paper
• Impact of high-throughput screening in biomedical research

  2011cited by this paper
• Discovery and pharmacological characterization of N-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide hydrochloride (anagliptin hydrochloride salt) as a potent and selective DPP-IV inhibitor.

  2011cited by this paper
• Direct renin inhibitors as a new therapy for hypertension.

  2010cited by this paper
• Current strategies for diversity-oriented synthesis.

  2010cited by this paper
• The Year's New Drugs & Biologics - 2009.

  2010cited by this paper
• Abiraterone acetate

  2009cited by this paper
• The year's new drugs & biologics - 2008.

  2009cited by this paper
• The year's new drugs and biologics--2007.

  2008cited by this paper
• The year's new drugs and biologics--2006.

  2007cited by this paper
• Modern synthetic efforts toward biologically active terpenes.

  2007cited by this paper
• Natural products as sources of new drugs over the last 25 years.

  2007cited by this paper
• A practical view of 'druggability'.

  2006cited by this paper
• The year's new drugs.

  2006cited by this paper
• Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: effects of linker technology on efficacy and toxicity.

  2006cited by this paper
• Critical review of the role of HTS in drug discovery.

  2006cited by this paper
• Stereocontrolled solid-phase synthesis of a 90-membered library of indoline-alkaloid-like polycycles from an enantioenriched aminoindoline scaffold.

  2005cited by this paper
• The year's new drugs.

  2005cited by this paper

• Viscum album L. mother tinctures modulate Na+/K+ ATPase activity and expression, and promote endothelium-dependent vasodilation via SK channel and nitric oxide signalling

  2026cites this paper
• Hierarchically engineered multi-enzyme nanoreactors for in vitro drug biosynthesis and pathway transplantation into cells

  2026cites this paper
• Chemical Language Models for Natural Products: A State-Space Model Approach

  2026cites this paper
• Malva sylvestris Flower Extract Exhibits Antineoplastic Potential Against Human Colon Cancer Cell Lines and Induces CDK2 Transcript Instability via Plant miR160-5p

  2026cites this paper
• Synthesis, docking, molecular dynamics, and biological evaluation of new hybrid dihydropyridine-pyrazole derivatives against breast cancer

  2026cites this paper
• Camphor's Therapeutic Uses and Potential Hazards: An In-Depth Review of Its Medicinal Applications.

  2026cites this paper
• Advancing the modernization of traditional Chinese medicine through artificial intelligence and multimodal data integration

  2026cites this paper
• Phytopharmacology in the Nanotech Era: Bridging Natural Compounds with Pharmaceutical Nanocarriers

  2026cites this paper
• Synthesis, Cholinesterase Inhibitory Activity, and Integrated DFT–Docking Study of Quinoline–Pyrene Hybrid Molecules

  2026cites this paper
• Clausenidin from Clausena excavata Burm. causes Apoptosis of Liver Cancer in Mice.

  2026cites this paper
• Molecular Hybridization Strategy for Developing Lipid‐Lowering Compounds: Design and Synthesis of Vanillin‐Based Fibrate Derivatives

  2026cites this paper
• DAP-seq Reveals Cluster-Situated Regulator Control of Numerous Streptomyces Natural Product Biosynthetic Genes

  2026cites this paper
• Phytochemical Profiling, In Silico Analysis, and In Vitro Assessment of Antioxidant and Anticancer Activities of Methanolic Extracts from Momordica cochinchinensis (Lour.) Spreng. Leaf and Fruit

  2026cites this paper
• Pinus morrisonicola induces cell-cycle arrest in human lung adenocarcinoma by modulating cyclins and cyclin-dependent kinases via p53-dependent signaling pathway

  2026cites this paper
• Rewiring Steroidal Metabolic Pathways for Diosgenin Production in Solanum nigrum.

  2026cites this paper
• Impacts of Herbal Medicine Use on Lipid Profiles in Type 2 Diabetic Patients in Northwest Ethiopia: A Comparative Cross‐Sectional Study

  2026cites this paper
• Exploring natural products as Bcl-2 inhibitors for acute myeloid leukemia therapy using In vitro, STD-NMR spectroscopy, and In silico approaches.

  2026cites this paper
• Applying nanotechnology to biotechnology: Boosting production and delivery of plant-derived secondary metabolites as therapeutic drugs

  2026cites this paper
• Beyond nature: in vivo production of natural product analogues through programmed biosynthetic pathways.

  2026cites this paper
• Evaluation of the Antifungal and Cytotoxic Potential of Crude Extracts from Sterculia foetida L. Seeds—Bulbostylis capillaris (L.) Kunth ex CB Clarke and Pouteria caimito (Ruiz and Pav.) Radlk in Candida spp.

  2026cites this paper
• Dandelion (Taraxacum mongolicum Hand. -Mazz.) extract inhibits triple-negative breast cancer by inducing ferroptosis via NCOA4-mediated ferritinophagy.

  2026cites this paper
• Iron-based dendritic nanostructures incorporating curcumin and ibuprofen for possible multi-therapeutic applications

  2026cites this paper
• Special Issue “Biosynthesis and Application of Natural Compound”

  2026cites this paper
• Anti-Sporothrix brasiliensis potential and anti-biofilm activity of Psidium guajava L. hydroacetone extract.

  2026cites this paper
• Oro-nasal film spray with andrographolide blocks SARS-CoV-2 and influenza infections and strengthens mucosal innate immunity

  2026cites this paper
• Immunomodulatory Effects of Medicinal Plants.

  2026cites this paper
• Marine Bacteria as a Source of Antibiotics Against Staphylococcus aureus: Natural Compounds, Mechanisms of Action, and Discovery Strategies

  2026cites this paper
• Natural cadinane-type sesquiterpenoids and their bioactivity: a review (2015-2025).

  2026cites this paper
• Natural supplements effectively suppress Helicobacter pylori colonization and improve gastric antioxidant and antiinflammatory responses in an indomethacin-induced ulcer model.

  2026cites this paper
• Natural Products Targeting Key Molecular Hallmarks in Gastric Cancer: Focus on Apoptosis, Inflammation, and Chemoresistance

  2026cites this paper
• Anti-cancer potential of polysaccharides derived from Tetrastigma hemsleyanum Diels et Gilg against human ovarian cancer cells in vitro.

  2026cites this paper
• Investigating the role of cytochrome bd oxidases in the antibacterial activity of madecassic acid and derivatives thereof.

  2026cites this paper
• Production of Bioethanol from Cordia dichotoma and Physalis minima

  2026cites this paper
• Research progress of 3-n-butylphthalide and its derivatives in combating cerebral ischemia.

  2026cites this paper
• Genomics must catch up with medicinal and aromatic plants: From neglect to equity in natural product research

  2026cites this paper
• Forest of Ilm: A Tawhidic Reflection on Nature and Pharmaceutical Knowledge and Research

  2026cites this paper
• Dendrophthoe pentandra (L.) Miq. as a Source of Anticancer Agents: A Review of Phytochemical Constituents and Preclinical Efficacy

  2026cites this paper
• Purification of a Plant-Based Bioactive Compound Aided by Geometric Calculation of a Quasi-Ternary Phase Diagram: The Case of Piperine

  2026cites this paper
• Hydrodistillation, comparative analysis and optimization of essential oils from Thymus schimperi R, Thymus serrulatus R, and Ocimum lamiifolium Hochst ex Benth.

  2026cites this paper
• Targeting Warburg effect: involvement of lactate transporter MCT1 and its chaperone in cancer cell killing by 18β-glycyrrhetinic acid.

  2026cites this paper
• The Science of the New

  2026cites this paper
• El Valor de las Plantas Medicinales en la Salud Comunitaria una Mirada Ancestral y Científica

  2026cites this paper
• Untargeted GC–MS metabolic profiling of Eurotium chevalieri AUMC 16390 (PX498623) reveals a putative steroidal metabolite with antibacterial and anti-inflammatory potential

  2026influential citation
• Anticancer activity of Citrus limon (L.) Burm. f. and Citrus sinensis (L.) Osbeck essential oil and their nanoemulsions

  2025cites this paper
• Homocapsaicin II induce ferroptosis in colorectal cancer cells via cholesterol-centrosome amplification-multipolarity axis.

  2025cites this paper
• Assessing The Effectiveness of Webinars in Delivering Knowledge of Natural Products and Pharmapreneurship

  2025cites this paper
• In Silico and In Vitro Analysis of Justicia adhatoda Methanol Extract: Molecular Docking Insights and a Promising Approach for Drug Discovery

  2025cites this paper
• Exploring Macrocyclic Chemical Space: Strategies and Technologies for Drug Discovery

  2025cites this paper
• 2‐Hydroxy‐3‐(Pyrrolidin‐1‐yl)‐Indolines: A Platform for Accessing Decorated Deaminokynurenines Enabled by a Double Tautomeric Control

  2025cites this paper
• Harnessing the Power of Natural Terpenoid Compounds Against Esophageal Squamous Cell Carcinoma: A Systematic Review

  2025cites this paper
• Plants from the Annonaceous family acting on the Central Nervous System: A comprehensive review to identify potential species

  2025cites this paper
• Non-Animal Hyaluronic Acid from Tremella fuciformis: A New Source with a Structure and Chemical Profile Comparable to Hyaluronic Acid

  2025influential citation
• 6-Methoxyflavone inhibits glycolytic energy metabolism in HeLa cells

  2025cites this paper
• Pyrone Biomonitored Synthesis

  2025cites this paper
• Combining network pharmacology and experimental verification to explore the inhibitory effects of Deoxyelephantopin (DET) Against Non-Small Cell Lung Cancer (NSCLC)

  2025cites this paper
• Natural product-based nanotechnological formulations for colorectal cancer treatment

  2025cites this paper
• Catechin designates individual and co-adjuvant antiproliferative effects with docetaxel in prostate cancer cell models.

  2025cites this paper
• Bioactivity-guided isolation of inositol as acetylcholinesterase inhibitory from endemic Campanula baskilensis Behcet: In vitro bioactivity, PCA analysis, and silico supporting studies

  2025cites this paper
• Molecular Docking and Molecular Dynamics Study of Propolis Compounds of Sulabiroin-A, Sulabiroin-B, and Broussoflavonol F Toward Tuberculosis 3PTY Target Protein

  2025cites this paper
• Can Caenorhabditis elegans Serve as a Reliable Model for Drug and Nutraceutical Discovery?

  2025cites this paper
• Comprehensive Evaluation of Essential Oil from Stemodia viscosa Roxb: Chemical Composition, Antimicrobial, Antimycobacterial, Antiangiogenic, and Anticancer Potential with Apoptosis and Cell Cycle Analysis

  2025cites this paper
• Total synthesis of natural products via conjugated ynone intermediates: a new millennium update.

  2025cites this paper
• Arthropod venom peptides: Pioneering nanotechnology in cancer treatment and drug delivery

  2025cites this paper
• Development of Adaptogens of Various Etiologies with Specified Properties Ensuring the Resistance of Living Systems to the Influence of External Factors and Mutations

  2025cites this paper
• Cytotoxic activity of methanolic and ethanolic extract of Aquilaria agallocha Roxb. heartwood against healthy fibroblast and breast cancer cells

  2025cites this paper
• LC‐DAD‐MSn and HR‐LC‐QTOF Analysis of Ziziphus budhensis Leaves and Evaluation of Their In Vitro and In Vivo Biological Activities

  2025cites this paper
• DNA binding studies of abietane diterpenes natural products using isothermal titration calorimetry, circular dichroism, fluorescence and gel assays.

  2025cites this paper
• Echinatin inhibits the growth and metastasis of human hepatocellular carcinoma cells through p38 and JNK signaling pathways.

  2025cites this paper
• Antioxidant Potential of Seed Extracts of Cucurbita Pepo, Ocimum Basillicum, Trachyspermum Ammi and Linum Usitatissimum - Individual and Synergistic Effect

  2025cites this paper
• Searching potential GSK-3β inhibitors from marine sources using atomistic simulations

  2025cites this paper
• Review on the Ethnopharmacological Use of Medicinal Plants and Their Anticancer Activity from Preclinical to Clinical Trial

  2025cites this paper
• Antimicrobial Analysis of extracts of rhizomes of hedychium Spicatum in A. Rees of Himachal Pradesh.

  2025cites this paper
• Bioactives From Brown Algae: Antioxidant, Anti‐Inflammatory, Anticancer, and Antimicrobial Potential

  2025cites this paper
• Antimicrobial evaluation of methanol and aqueous extracts of Cassia siamea leaf and stem bark

  2025cites this paper
• Biocontrol Potential of Borrelidin Metabolites Derived from Streptomyces rochei A144 as a Fungicide.

  2025cites this paper
• Metal-free Cross-Dehydrogenative Coupling for α-Arylation of 3-Aryloxindoles.

  2025cites this paper
• NaFM: Pre-training a Foundation Model for Small-Molecule Natural Products

  2025cites this paper
• Tangeretin regulates oxidative stress in cutaneous melanoma cells via the Nrf2 signaling pathway

  2025cites this paper
• Kwas Karnozynowy w Nowotworzeniu: od Teorii do Praktyki

  2025cites this paper
• Study on the Mechanism of Formononetin Against Hepatocellular Carcinoma: Regulating Metabolic Pathways of Ferroptosis and Cell Cycle

  2025cites this paper
• Synthesis of Thioloformate-Containing Lathyrane Diterpene Derivates via a [3,3] Sigmatropic Rearrangement and Their Anti-HIV Activity.

  2025cites this paper
• Antiviral Effect and Metabolic Regularity of a Phenylpropanoid- Based Compound as Potential Immunopotentiator

  2025cites this paper
• 11C-Labeling of a Flavanone Extracted from a South American Native Species for Evaluation of Its Interaction with GSK-3β

  2025cites this paper
• Antifungal Natural Products Originating from Endophytic and Rhizospheric Microbes Isolated from Coastal Vegetation

  2025cites this paper
• Design and semisynthesis of novel oleanolic acid-based tertiary amide derivatives as promising antifungal agents against phytopathogenic fungi

  2025cites this paper
• Cytotoxicity, acute and subchronic toxicity of the methanol extract from the fruits of Psorospermun febrifugum Spach (Hypericaceae) in Wistar albino rats

  2025cites this paper
• A Path to the Formation Mechanism of Propolis Nanoparticles, their Cytotoxicity on 3T3 Fibroblasts, Metastatic Murine B16F10 Cells, and their In vivo Irritability in Animals.

  2025cites this paper
• CANDI: a web server for predicting molecular targets and pathways of cannabis-based therapeutics

  2025cites this paper
• GCMS, phytochemical analysis, biological potential of dichloromethane extract of Yucca elephantipes regel roots: in vitro and in silico studies.

  2025cites this paper
• Recent progress in chemistry and bioactivity of novel enzyme inhibitors from natural products: A comprehensive review.

  2025cites this paper
• A Systems Biology Approach to Understanding Delirium Pathophysiology and Identifying Natural Compounds for Potential Therapeutic Purposes

  2025cites this paper
• A review of recent advances in anticancer activity and SAR of pyrazole derivatives

  2025cites this paper
• Protective effect of Astragalus polysaccharide on diabetic nephropathy: A systematic review and meta‑analysis reveals the efficacy and potential mechanisms

  2025cites this paper
• A polyene macrolide targeting phospholipids in the fungal cell membrane

  2025cites this paper
• In-vitro Antibacterial Activity of Extracts from Twenty Four Plants Species against Salmonella typhi in North-East Nigeria

  2025cites this paper
• Role of MMP inhibitors on levels of MMP-2 and MMP-9 in mammalian cell lines – A systematic review

  2025cites this paper
• Deciphering the Anticancer, Antioxidant, Enzyme Inhibition Potentials, and Phytochemical Compositions of Some Endemic Centaurea Species

  2025cites this paper
• Neuropharmacology and the Applications of Herbal Extracts Found within Sri Lankan Traditional Anxiety Remedies

  2025cites this paper
• Advanced Integrated Molecular Simulations Based Prediction of Sulfonamide Natural Compound Binding to Cytosolic Carbonic Anhydrase Enzymes

  2025cites this paper
• Sesquiterpene Lactones as Promising Phytochemicals to Cease Metastatic Propagation of Cancer

  2025cites this paper